Holders over time
- CI
- ELV
| Quarter | CI | ELV |
|---|---|---|
| Q3 2020 | 34 holders, $18.1bn | 30 holders, $15.0bn |
| Q4 2020 | 22 holders, $21.9bn | 29 holders, $16.7bn |
| Q1 2021 | 24 holders, $23.9bn | 25 holders, $18.6bn |
| Q2 2021 | 31 holders, $22.5bn | 30 holders, $19.4bn |
| Q3 2021 | 30 holders, $17.8bn | 26 holders, $18.5bn |
| Q4 2021 | 26 holders, $20.1bn | 29 holders, $23.3bn |
| Q1 2022 | 28 holders, $20.4bn | 31 holders, $23.9bn |
| Q2 2022 | 32 holders, $22.1bn | 32 holders, $23.3bn |
| Q3 2022 | 31 holders, $21.5bn | 34 holders, $22.6bn |
| Q4 2022 | 30 holders, $24.7bn | 34 holders, $25.5bn |
| Q1 2023 | 35 holders, $18.2bn | 39 holders, $22.5bn |
| Q2 2023 | 30 holders, $19.8bn | 38 holders, $20.6bn |
| Q3 2023 | 28 holders, $19.8bn | 34 holders, $19.8bn |
| Q4 2023 | 31 holders, $20.6bn | 36 holders, $20.3bn |
| Q1 2024 | 28 holders, $24.0bn | 35 holders, $21.3bn |
| Q2 2024 | 28 holders, $19.5bn | 33 holders, $22.1bn |
| Q3 2024 | 25 holders, $20.2bn | 30 holders, $20.2bn |
| Q4 2024 | 23 holders, $15.2bn | 32 holders, $15.9bn |
| Q1 2025 | 24 holders, $18.4bn | 28 holders, $17.1bn |
| Q2 2025 | 34 holders, $19.5bn | 27 holders, $14.8bn |
| Q3 2025 | 28 holders, $16.2bn | 27 holders, $12.7bn |
| Q4 2025 | 21 holders, $14.6bn | 25 holders, $17.0bn |
| Q1 2026 | 26 holders, $13.5bn | 26 holders, $13.6bn |
| Q2 2026 | 28 holders, $13.0bn | 28 holders, $17.7bn |
The Cigna Group
- Holders
- 34
- Reported value
- $19.5bn
- Buyers
- 24
- Sellers
- 10
Breadth +14 among 95 comparable managers.
Elevance Health Inc Formerly
- Holders
- 27
- Reported value
- $14.8bn
- Buyers
- 13
- Sellers
- 16
Breadth -3 among 95 comparable managers.
Who holds both, Q2 2025
Both (19)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Invesco Ltd, Man Group PLC, MFS Investment Management, Moore Capital Management LP, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Investments LP
Only CI (15)
Balyasny Asset Management LLC, Capital World Investors, Citadel Advisors LLC, Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Greenlight Capital, Jane Street Group LLC, Marshall Wace LLP, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Two Sigma Advisers LP, Winton Group Ltd, Woodline Partners LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.